Autonomix Medical, Inc. (AMIX)
Insiders here have filed 4 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$16.1M
- Net margin
- —
Little or no net debt.
- Total debt
- $0
- Cash
- $3.5M
- Debt / equity
- 0.00
Comfortably covers what is due within a year.
- Current assets
- $4.0M
- Current liabilities
- $818K
- Current ratio
- 4.85
Consumes cash and must keep raising it.
- Operating cash flow
- -$12.1M
- Free cash flow
- -$12.1M
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 0.5M
- Share growth (1y)
- 267.7%
- Cash runway
- 3 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
AMIX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| SG&A Expense | 1.25 M | 1.28 M | 1.62 M | 5.17 M | 1.83 M |
| R&D Expense | 1.51 M | 1.46 M | 1.72 M | 2.37 M | 1.59 M |
| Operating Expenses | 2.77 M | 2.74 M | 3.34 M | 7.53 M | 3.42 M |
| Operating Income | -2.77 M | -2.74 M | -3.34 M | -7.53 M | -3.42 M |
| Pretax Income | -2.73 M | -2.67 M | -3.26 M | -7.45 M | -3.34 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -2.73 M | -2.67 M | -3.26 M | -7.45 M | -3.34 M |
| EPS (Basic) | -5.02 | — | -7.56 | -28.98 | -22.69 |
| EPS (Diluted) | -5.02 | — | -7.56 | -28.98 | -22.69 |
| Shares Outstanding | 543.68 K | — | 426.47 K | 257.70 K | 147.06 K |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.